Cite

HARVARD Citation

    Ensor, C. et al. (2017). Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation. Clinical transplantation. 31 (4), p. n/a. [Online]. 
  
Back to record